Catalyst Wire Dossier Catalyst Wire Dossier

Bexotegrast (PLN-74809)

bexotegrast · Pliant Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bexotegrast (PLN-74809), covering 2025-08-01 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis [Phase 2]

See pricing